Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company 2019-11-08 21:24
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial 2019-11-08 21:00
SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe 2019-11-08 17:36
Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes 2019-11-08 11:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 21:02
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million 2019-11-07 19:04
Bactiguard Holding AB (publ): Interim Report for Q3 2019 2019-11-07 15:23
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-11-07 11:02
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S. 2019-11-07 05:14
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364 2019-11-07 01:40
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019 2019-11-07 01:00
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports 2019-11-06 18:01
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation 2019-11-06 17:21
15 Years of P-MEC China Driving Global Pharma Technology Forward in China 2019-11-06 14:00
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab) 2019-11-05 21:00
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
Health Charities Benefit from Nationwide Fundraising Campaign 2019-11-05 05:30
1 324 325 326 327 328 423